search
Back to results

Increasing Potassium Intake in Hypertensive Individuals

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
High potassium diet
Sponsored by
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring Nutrition, Potassium

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Medically treated hypertension as diagnosed Hypertension was established by the participant's cardiologist or if recruited from the online community hypertension was self-reported and confirmed by study investigators based on participant's medical prescription.
  • Treatment with an beta blocker, ACE inhibitor, or angiotensin receptor blocker without any adjustment over the previous 3 months
  • K+ intake at baseline of less than 80 mmol/day (food diary of 24 hour food recall).

Exclusion Criteria:

  • Patients with an episode of acute coronary syndrome, or revascularization within the previous 3 months will not be included.
  • Serum K+ concentration 5.0 mmol/L
  • Serum creatinine > 130 mmol/L.
  • Inability to provide informed consent.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    High potassium diet group

    Usual diet group

    Arm Description

    Individuals in this arm were asked to increase dietary potassium intake over a 4 week period. This was achieved through an increase in consumption of fruits and vegetables.

    Individuals in this group were asked to continue habitual dietary intake.

    Outcomes

    Primary Outcome Measures

    Serum potassium concentration

    Secondary Outcome Measures

    24 hour urinary potassium excretion
    3 day dietary food diary
    Food record will assess marco and mirco nutrient intake.

    Full Information

    First Posted
    December 22, 2015
    Last Updated
    May 23, 2017
    Sponsor
    Samuel Lunenfeld Research Institute, Mount Sinai Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02759367
    Brief Title
    Increasing Potassium Intake in Hypertensive Individuals
    Official Title
    Adequate Intake of Potassium Does Not Cause Hyperkalemia in Hypertensive Individuals on Medications That Antagonize the Renin Angiotensin Aldosterone System
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2017
    Overall Recruitment Status
    Completed
    Study Start Date
    March 2008 (undefined)
    Primary Completion Date
    June 2015 (Actual)
    Study Completion Date
    June 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Samuel Lunenfeld Research Institute, Mount Sinai Hospital

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This study evaluates the safety of increasing dietary potassium intake in a hypertensive population that may be at risk for hyperkalemia.
    Detailed Description
    The blood pressure lowering benefits of increasing dietary potassium (K⁺) are well known. As such dietary recommendations for hypertension focus on a diet rich in high K⁺ food sources such as fruits and vegetables. An important theme to be addressed is the safety of achieving high dietary K⁺ intake in hypertensive individuals who are also receiving medical therapy that might predispose to elevated serum K⁺ levels (hyperkalemia). The purpose of this study was to assess the impact of aggressively increasing dietary K⁺ on serum K⁺ concentrations in hypertensive individuals with intact renal function medicated with RAAS blocking drugs. The investigators hypothesized that dietary K⁺ supplementation would not provoke hyperkalemia despite treatment with either an angiotensin converting enzyme (ACEi) or an angiotensin receptor blocker (ARB). The investigators conducted an open controlled clinical trial in 20 hypertensive subjects with normal renal function who were randomized to a usual diet group (UD n=10), or a high potassium diet group (HKD, n= 10). Fruits and vegetables were used to increase potassium intake. All participants were on an ACEi or and ARB. Serum potassium concentration, 3- day food records and 24 Hour urine collections were completed at baseline and at the end of the 4-week study.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Hypertension
    Keywords
    Nutrition, Potassium

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Masking Description
    Treating physicians and participants were not blinded to randomization. Investigators performing randomization and analysis of dietary intake were blinded.
    Allocation
    Randomized
    Enrollment
    20 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    High potassium diet group
    Arm Type
    Experimental
    Arm Description
    Individuals in this arm were asked to increase dietary potassium intake over a 4 week period. This was achieved through an increase in consumption of fruits and vegetables.
    Arm Title
    Usual diet group
    Arm Type
    No Intervention
    Arm Description
    Individuals in this group were asked to continue habitual dietary intake.
    Intervention Type
    Other
    Intervention Name(s)
    High potassium diet
    Intervention Description
    An increase in consumption of high potassium fruits and vegetables
    Primary Outcome Measure Information:
    Title
    Serum potassium concentration
    Time Frame
    4 weeks
    Secondary Outcome Measure Information:
    Title
    24 hour urinary potassium excretion
    Time Frame
    4 weeks
    Title
    3 day dietary food diary
    Description
    Food record will assess marco and mirco nutrient intake.
    Time Frame
    4 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    85 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Medically treated hypertension as diagnosed Hypertension was established by the participant's cardiologist or if recruited from the online community hypertension was self-reported and confirmed by study investigators based on participant's medical prescription. Treatment with an beta blocker, ACE inhibitor, or angiotensin receptor blocker without any adjustment over the previous 3 months K+ intake at baseline of less than 80 mmol/day (food diary of 24 hour food recall). Exclusion Criteria: Patients with an episode of acute coronary syndrome, or revascularization within the previous 3 months will not be included. Serum K+ concentration 5.0 mmol/L Serum creatinine > 130 mmol/L. Inability to provide informed consent.

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    27581475
    Citation
    Malta D, Arcand J, Ravindran A, Floras V, Allard JP, Newton GE. Adequate intake of potassium does not cause hyperkalemia in hypertensive individuals taking medications that antagonize the renin angiotensin aldosterone system. Am J Clin Nutr. 2016 Oct;104(4):990-994. doi: 10.3945/ajcn.115.129635. Epub 2016 Aug 31.
    Results Reference
    derived

    Learn more about this trial

    Increasing Potassium Intake in Hypertensive Individuals

    We'll reach out to this number within 24 hrs